Beata K. Z.
- Country
- Poland
- Department
- Oncology
Research Overview
- Phase 3 Randomized Study of Tarlatamab Versus Placebo in Limited-Stage Small-Cell Lung Cancer Post-Concurrent Chemoradiation Therapy
- Phase 2 Randomized Double-Blind Placebo-Controlled Study of Ponsegromab in Cancer Cachexia with Elevated GDF-15 Concentrations
- Phase 3 Randomized Study of MK-7684A with Etoposide and Platinum vs. Atezolizumab for First-Line Treatment of Extensive-Stage Small Cell Lung Cancer
Data & Insights
Has run more than one trial at 70 of 216 partner sites.
Specializations
Oncology Research
The investigator specializes in the treatment of extensive-stage small-cell lung cancer (ES-SCLC), focusing on innovative therapeutic approaches for this aggressive form of lung cancer.
- Advanced Lung Cancer Management
- Combination Therapy Strategies
- Immunotherapy Applications
Through clinical research, the investigator explores novel treatment combinations incorporating immunotherapy with traditional chemotherapy regimens for lung cancer patients.
Therapeutic Innovation
The investigator's work centers on evaluating new therapeutic combinations for advanced lung cancer treatment, particularly examining the efficacy of various drug combinations with platinum-based therapies.
- Novel Drug Combinations
- Treatment Optimization
- Survival Outcomes
Research activities focus on comparing different therapeutic approaches to enhance overall survival rates in patients with extensive-stage disease.
Clinical Applications
The investigator conducts research in advanced therapeutic protocols for lung cancer treatment, with particular attention to combining multiple treatment modalities.
- Treatment Protocol Development
- Patient Response Assessment
- Therapeutic Strategy Evaluation
Their work encompasses the evaluation of targeted therapy combinations and their impact on patient outcomes in advanced lung cancer scenarios.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.